Standpoint Research Initiates Coverage on McKesson (MCK) with a Buy; Best-Positioned to Benefit From Increased Demand in Generics

January 19, 2010 7:32 AM EST Send to a Friend
Standpoint Research initiates coverage on McKesson Corporation (NYSE: MCK) with a Buy rating. Price target range $70-$75.

Standpoint analyst says ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login